Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis.

Theivanthiran, Balamayooran; Haykal, Tarek; Cao, Linda; Holtzhausen, Alisha; Plebanek, Michael; DeVito, Nicholas C; Hanks, Brent A.

Afiliação

Theivanthiran B; Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC 27708, USA.
Haykal T; Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC 27708, USA.
Cao L; Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC 27708, USA.
Holtzhausen A; Lineburger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Plebanek M; Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC 27708, USA.
DeVito NC; Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC 27708, USA.
Hanks BA; Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC 27708, USA.

Cancers (Basel) ; 13(19)2021 Sep 23.

Article em En | MEDLINE | ID: mdl-34638239